Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1979 Feb;60(1):45–57.

Thiamphenicol and lupus nephritis. The effects of long-term therapy on kidney function and pathology: a pilot study.

L O Simpson, I Aarons, J B Howie
PMCID: PMC2041425  PMID: 157149

Abstract

NZB x OUW F1 hybrid mice were treated with thiamphenicol at 25, 50 and 250 mg/kg/day from the time of their first positive antinuclear antibody test until their death. Untreated mice fed the same diet served as controls with body weight, mortality and renal disease patterns conforming to published reports of the biology of the BW mice. Regular testing of urine and bloodm and detailed postmortem examinations showed (a) that with increasing drug dose levels heavy proteinuria was almost eliminated and blood urea concentrations significantly lowered; (b) that in treated and untreated mice moderate to severe anaemia developed, apparently unrelated to the degree of uraemia; (c) that changes in renal function did not correlate with antinuclear antibody activity, nor did the drop in packed cell volume correlate with fixed or free circulating antierythrocyte autoantibody positivity; (d) that histological analysis of renal changes showed that at the highest dose level glomerular lesions were minimal. Thus the prolonged treatment with thiamphenicol reduced the severity of the spontaneous renal disease and resulted in a significant extension of lifespan.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burnet F. M., Holmes M. C. The natural history of the NZB/NZW F1 hybrid mouse: a laboratory model of systemic lupus erythematosus. Australas Ann Med. 1965 Aug;14(3):185–191. doi: 10.1111/imj.1965.14.3.185. [DOI] [PubMed] [Google Scholar]
  2. Casey T. P. Immunosuppression by cyclophosphamide in NZB X NZW mice with lupus nephritis. Blood. 1968 Sep;32(3):436–444. [PubMed] [Google Scholar]
  3. Casey T. P. Systemic lupus erythematosus in NZB x NZW hybrid mice treated with the corticosteroid drug betamethasone. J Lab Clin Med. 1968 Mar;71(3):390–399. [PubMed] [Google Scholar]
  4. Casey T. P. The development of lymphomas in mice with autoimmune disorders treated with azathioprine. Blood. 1968 Mar;31(3):396–399. [PubMed] [Google Scholar]
  5. DUNN T. B. Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms. J Natl Cancer Inst. 1954 Jun;14(6):1281–1433. [PubMed] [Google Scholar]
  6. Dixon F. J., Oldstone M. B., Tonietti G. Pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med. 1971 Sep 1;134(3 Pt 2):65s–71s. [PubMed] [Google Scholar]
  7. Dubois E. L., Horowitz R. E., Demopoulos H. B., Teplitz R. NZB/NZW mice as a model of systemic lupus erythematosus. JAMA. 1966 Jan 24;195(4):285–289. [PubMed] [Google Scholar]
  8. Gelfand M. C., Steinberg A. D., Nagle R., Knepshield J. H. Therapeutic studies in NZB-W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination. Arthritis Rheum. 1972 May-Jun;15(3):239–246. doi: 10.1002/art.1780150304. [DOI] [PubMed] [Google Scholar]
  9. Gelfand M. C., Steinberg A. D. Therapeutic studies in NZB-W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone. Arthritis Rheum. 1972 May-Jun;15(3):247–252. doi: 10.1002/art.1780150305. [DOI] [PubMed] [Google Scholar]
  10. Horowitz R. E., Dubois E. L., Weiner J., Strain L. Cyclophosphamide treatment of mouse systemic lupus erythematosus. Lab Invest. 1969 Sep;21(3):199–206. [PubMed] [Google Scholar]
  11. MUEHRCKE R. C., KARK R. M., PIRANI C. L., POLLAK V. E. Lupus nephritis: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) 1957 Feb;36(1):1–145. [PubMed] [Google Scholar]
  12. Mathews M. B., Hunt T., Brayley A. Specificity of the control of protein synthesis by haemin. Nat New Biol. 1973 Jun 20;243(129):230–233. doi: 10.1038/newbio243230a0. [DOI] [PubMed] [Google Scholar]
  13. POLLAK V. E., PIRANI C. L., KARK R. M. Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis. J Lab Clin Med. 1961 Apr;57:495–511. [PubMed] [Google Scholar]
  14. Russell P. J., Hicks J. D. Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice. Lancet. 1968 Mar 2;1(7540):440–441. doi: 10.1016/s0140-6736(68)92778-5. [DOI] [PubMed] [Google Scholar]
  15. Slavin R. G., Gallagher N. I. Lymphocytopenia in acute experimental renal failure. Int Arch Allergy Appl Immunol. 1974;47(1):80–86. doi: 10.1159/000231202. [DOI] [PubMed] [Google Scholar]
  16. Walker S. E., Bole G. G., Jr Augmented incidence of neoplasia in NZB-NZW mice treated with long-term cyclophosphamide. J Lab Clin Med. 1973 Oct;82(4):619–633. [PubMed] [Google Scholar]
  17. Wilson C. B., Dixon F. J. Quantitation of acute and chronic serum sickness in the rabbit. J Exp Med. 1971 Sep 1;134(3 Pt 2):7s–8s. [PubMed] [Google Scholar]
  18. Zurier R. B., Damjanov I., Sayadoff D. M., Rothfield N. F. Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum. 1977 Nov-Dec;20(8):1449–1456. doi: 10.1002/art.1780200802. [DOI] [PubMed] [Google Scholar]
  19. Zurier R. B., Sayadoff D. M., Torrey A. B., Rothfield N. F. Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum. 1977 Mar;20(2):723–728. doi: 10.1002/art.1780200213. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES